News about Kovid-19 | Anvisa directs immediate suspension of use of AstraZeneca vaccine in pregnant women.

  News about Kovid-19 |  Anvisa directs immediate suspension of use of AstraZeneca vaccine in pregnant women.

Information to readers: EL PAÍS maintains the necessary information about coronovirus during the crisis. If you want to support our journalism, Please click here to subscribe. Subscribe to receive our free newsletter from Monday to Saturday with your email, reports, analysis, exclusive interviews and the most important information of the day Here.

more information

The National Health Monitoring Agency (Anvisa) recommends the immediate suspension of the use of the AstraZeneca vaccine in pregnant women without medical advice. The vaccination package included does not include this public, but the National Immunization Scheme (PNI) had guided the vaccination of pregnant women with comorbidities. Now, the Ministry of Health re-evaluates the guidance. On this second, Brazil recorded 889 more deaths. New coronavirus, In addition to 25,200 cases. There are now a total of 423,229 deaths and 15,209,990 infections. In the United States, the FDA has authorized youth between the ages of 12 and 15 to receive Pfizer’s COVID-19 vaccine. The New York governor has announced that he will need proof of vaccination from university students who are going to take classes face-to-face and will also place vaccination points at metro stations as a way to encourage vaccination campaigns. The World Health Organization (WHO) on Tuesday presented a report on the Indian version of the new coronovirus. “There is information that suggests greater potential for contagion,” says epidemiologist Maria Van Kerkhov from WHO’s emergency programs. WHO director Tedros Adhan argued that global cooperation and solidarity is the only option to win the world epidemic.

Follow the most important news of the day:

See also  China's trouble in Ukraine: Xi Jinping's heart flutters between Putin and Zelensky

LEAVE A REPLY

Please enter your comment!
Please enter your name here